10-Q: Onto Innovation Q1 2026: Revenue Up, Profit Down
Quarterly Report
Onto Innovation Inc. reports a 9.5% revenue increase to $291.9 million in Q1 2026, but net income fell significantly to $33.8 million, alongside a strategic $710 million investment in Rigaku Holdings.
Summary
- Revenue increased by 9.5% to $291.9 million for the three months ended March 31, 2026, compared to $266.6 million for the three months ended March 29, 2025.
- Net income decreased significantly by 47.3% to $33.8 million in Q1 2026 from $64.1 million in Q1 2025.
- Diluted earnings per share fell by 48.5% to $0.67 in Q1 2026 from $1.30 in Q1 2025.
- Gross profit as a percentage of revenue decreased to 50.1% in Q1 2026 from 53.7% in Q1 2025, primarily due to higher restructuring expenses and inventory step-up amortization from the Semilab USA acquisition.
- Operating expenses rose substantially by 40.9% to $112.9 million in Q1 2026 from $80.1 million in Q1 2025, driven by increased research and development, sales and marketing, general and administrative, amortization, and restructuring costs.
- Net cash provided by operating activities decreased significantly to $26.3 million in Q1 2026 from $92.0 million in Q1 2025.
- Cash, cash equivalents, and marketable securities increased to $654.2 million at March 31, 2026, from $639.6 million at January 3, 2026.
- The company announced a subsequent event to acquire 27% of Rigaku Holdings Corporation for approximately $710 million, expected to close in the second half of 2026.
- A $500 million senior secured 364-day bridge term loan credit facility from Goldman Sachs Bank USA was secured to help finance the Rigaku acquisition.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mixed report with strong revenue growth but a significant decline in profitability and operating cash flow, coupled with increased operating expenses. The strategic Rigaku investment is a long-term play, but the immediate financial performance shows challenges.
Positives
- Revenue increased by 9.5% year-over-year to $291.9 million, demonstrating top-line growth.
- The acquisition of Semilab USA contributed $27.1 million in revenue and $13.4 million in operating income in Q1 2026, indicating successful integration and contribution.
- Cash, cash equivalents, and marketable securities increased to $654.2 million at March 31, 2026, from $639.6 million at January 3, 2026, strengthening liquidity.
- Increased sales to advanced packaging customers reflect growth in a key market segment.
- Increased parts and services revenue due to system upgrades and repairs suggests a healthy installed base and customer engagement.
- The effective tax rate remains low at 11.3% due to Foreign Derived Intangible Income (FDII) deductions, federal research and development tax credits, and excess tax benefits associated with equity compensation.
Negatives
- Net income decreased significantly by 47.3% to $33.8 million in Q1 2026 from $64.1 million in Q1 2025.
- Diluted earnings per share decreased by 48.5% to $0.67 in Q1 2026 from $1.30 in Q1 2025.
- Gross profit margin declined by 3.6 percentage points to 50.1% from 53.7% year-over-year, impacted by higher restructuring and inventory step-up amortization.
- Operating expenses increased substantially by 40.9% year-over-year, driven by higher R&D, sales and marketing, general and administrative, amortization, and restructuring costs.
- Net cash provided by operating activities decreased substantially by 71.4% to $26.3 million from $92.0 million year-over-year, primarily due to timing of accounts receivable payments and higher inventory levels.
- Net cash used in investing activities increased significantly to $112.6 million from $21.8 million year-over-year, partly due to purchases of non-marketable equity securities.
- Interest income, net, decreased due to lower cash and marketable securities balances following the use of cash for the Semilab USA acquisition.
- Revenue from Taiwan and South Korea decreased year-over-year, indicating regional shifts or challenges.
Risks
- The ability to complete the Rigaku acquisition is subject to various closing conditions, including governmental approvals, which may impose conditions that could adversely affect the company or prevent the transaction.
- Uncertainty exists in realizing the anticipated benefits from the proposed investment in and strategic partnership with Rigaku.
- As a minority shareholder in Rigaku, the company will not be able to direct Rigaku's management or cause dividends or distributions to be made.
- The value of Rigaku shares could decline for reasons outside of the company's control, adversely affecting its financial position.
- Rigaku shares are subject to certain restrictions on transfer, which could make them difficult to sell.
- Dependence on certain significant customers, with Customer A, B, and C each accounting for over 10% of total revenue in Q1 2026.
- Fluctuations in customer capital spending could impact future revenue and profitability.
- The company's ability to effectively manage its supply chain and adequately source components from suppliers to meet customer demand is a risk due to potential delays or shortages.
- Effects of political, economic, legal, and regulatory changes or uncertainties, including U.S. tariff and trade policy, retaliatory actions, and geopolitical conflicts (e.g., the ongoing conflict involving Israel, the U.S., and Iran), could impact global operations.
- The ability to adequately protect intellectual property rights and maintain data security is crucial.
- Natural disasters or public health emergencies could affect the global economy, customers, suppliers, employees, and business.
- The company's ability to effectively maneuver global trade issues and changes in trade and export regulations, tariffs, and license policies is a continuous challenge.
- Potential for changes in tax legislation, the geographic composition of pre-tax income, and non-deductible expenses to affect the future effective income tax rate.
- The company holds marketable securities with aggregate unrealized losses of $175.5 million at March 31, 2026, with some investments in an unrealized loss position for greater than a year.
Future Outlook
The company expects its existing cash, cash equivalents, and marketable securities to be sufficient to meet anticipated cash requirements for working capital, capital expenditures, and other cash needs for the next 12 months. Beyond this period, additional funding may be sought through bank borrowings or sales of securities. The acquisition of 27% of Rigaku Holdings Corporation is anticipated to close in the second half of 2026.
Management Comments
- "We believe that it is critical to continue to make substantial investments in research and development to ensure the availability of innovative technology that meets the current and projected requirements of our customers most advanced designs."
- "We have maintained and intend to continue our commitment to investing in research and development in order to continue to offer new products and technologies."
- "We expect that our existing cash, cash equivalents and marketable securities will be sufficient to meet our anticipated cash requirements for working capital, capital expenditures, and other cash needs for the next 12 months following the filing of this Form 10-Q."
Industry Context
StockSavvy.ai notes that the semiconductor and electronics industries are characterized by constant technological innovation, driving demand for process control equipment as customers invest in advanced technologies for smaller design rules and higher density applications. The strategic investment in Rigaku Holdings Corporation, a leader in X-ray metrology, aligns with the industry's need for advanced materials characterization and quality control, potentially expanding Onto Innovation's market reach and product portfolio in a consolidating and technologically advancing sector.
Comparison to Industry Standards
- The semiconductor capital equipment market is highly competitive, with companies like KLA Corporation, Applied Materials, and Lam Research being key players in various segments of process control and manufacturing.
- Onto Innovation's focus on macro-defect inspection, metrology, lithography, and process control analytical software positions it within a specialized segment that is critical for yield enhancement in semiconductor fabrication.
- The acquisition of Semilab USA strengthens capabilities in inline wafer contamination monitoring and materials characterization, areas where industry leaders are continuously innovating to meet the demands of advanced node manufacturing.
- The strategic investment in Rigaku Holdings Corporation, a leader in X-ray metrology, suggests a move to enhance materials characterization capabilities, a trend seen across the industry to address increasing complexity in advanced materials and device structures.
- The decline in gross profit margin and net income, despite revenue growth, could indicate competitive pricing pressures or higher operational costs associated with new product introductions and integration activities, which are common challenges in the capital-intensive semiconductor industry where R&D and M&A are significant drivers.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Vice President, Product Solutions Group | Executive Vice President, Process Control Group | Ido Dolev | December 1, 2024 | Promotion/reorganization (Offer letter dated October 30, 2024) |
| Senior Vice President of Customer Success | Shirley Chen | June 16, 2025 | New hire (Offer letter dated May 16, 2025) |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Fiscal Year-End Change | The Board of Directors changed the company's fiscal year-end from a 52-53 week fiscal year ending closest to December 31 to a calendar December 31 fiscal year-end, and adopted calendar quarter fiscal period ends. | February 18, 2026 | Aims to improve navigability, applicability, and consistency of interim reporting, not expected to have a material impact on quarterly financial results. |
| Credit Facility Termination | The company terminated its $100.0 million variable-rate line of credit with a bank. | During the three months ended March 31, 2026 | The line of credit was not utilized while active, so its termination does not immediately impact liquidity, but removes a potential source of short-term funding. |
| Share Repurchase Authorization | The Board of Directors approved a share repurchase authorization of up to $200 million in February 2024, with $99.9 million remaining available. | February 2024 (authorization date) | Provides flexibility for capital allocation and potential shareholder returns, but no shares were repurchased in Q1 2026. |
| Rule 10b5-1 Trading Arrangements | Yoon Ah E. Oh (SVP, General Counsel, Corporate Secretary), Ido Dolev (EVP, Product Solutions Group), and Michael P. Plisinski (CEO) adopted Rule 10b5-1 trading arrangements for stock sales. | February 24, 2026 (Oh), February 25, 2026 (Dolev), March 9, 2026 (Plisinski) | These plans allow insiders to sell shares at predetermined times to avoid accusations of insider trading, reflecting planned liquidity events for executives. |
Legal Proceedings
- The company is subject to legal proceedings and claims in the ordinary course of business. Management believes any potential liabilities from current disputes would not have a material adverse effect on the unaudited interim condensed consolidated financial statements.
Stakeholder Impact
- Shareholders: Experience a significant decline in net income and EPS, but also benefit from revenue growth and a strategic long-term investment in Rigaku. The remaining share repurchase authorization offers potential future capital returns.
- Employees: Increased headcount in several departments, but also subject to restructuring plans that include workforce reductions and severance costs.
- Customers: Benefit from increased spending on system upgrades and repairs, and the strengthening of capabilities through the Semilab USA acquisition. Sales to advanced packaging customers are up, but advanced node sales are down.
- Suppliers: Face potential impacts from supply chain delays or shortages, which the company is actively managing.
- Creditors: The company has secured a new $500 million bridge term loan facility, increasing its debt obligations, primarily for the Rigaku acquisition.
Next Steps
- Complete the acquisition of 27% of Rigaku Holdings Corporation, expected in the second half of 2026.
- Integrate Semilab USA LLC business and technologies to realize anticipated benefits.
- Continue substantial investments in research and development to offer new products and technologies.
- Monitor U.S. and international legislative developments regarding global minimum tax rules (Pillar Two) and other tax reforms.
- Evaluate the potential impact of new accounting standards (ASU 2025-10, ASU 2025-09, ASU 2025-06, ASU 2024-03) on financial statements.
- Potentially seek additional funding through bank borrowings or sales of securities if cash generated from operations and financing activities is insufficient to satisfy working capital requirements beyond the next 12 months.
Key Dates
| Date | Description |
|---|---|
| October 30, 2024 | Offer letter to Ido Dolev for Executive Vice President, Process Control Group. |
| December 1, 2024 | Projected start date for Ido Dolev as Executive Vice President, Process Control Group. |
| December 28, 2024 | Balance sheet date for the prior fiscal year's first quarter. |
| December 29, 2024 | Commencement of the three-month period ended March 29, 2025. |
| February 2024 | Board of Directors approved a share repurchase authorization of up to $200 million. |
| March 29, 2025 | End of the three-month period for the prior fiscal year's first quarter. |
| May 16, 2025 | Offer letter to Shirley Chen for Senior Vice President of Customer Success. |
| June 16, 2025 | Projected start date for Shirley Chen as Senior Vice President of Customer Success. |
| June 27, 2025 | Date of the original Equity Purchase Agreement for Semilab USA LLC. |
| July 1, 2025 | Deadline for Ido Dolev's family relocation to Massachusetts. |
| July 4, 2025 | United States enacted tax reform legislation through the One Big Beautiful Bill Act. |
| September 2025 | FASB issued ASU 2025-06, Intangibles-Goodwill and Other-Internal Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. |
| October 9, 2025 | Amendment to Equity Purchase Agreement for Semilab USA LLC. |
| November 17, 2025 | Acquisition of Semilab USA LLC completed. |
| November 2024 | FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40). |
| December 2025 | FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements. |
| December 2025 | FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. |
| December 2025 | FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. |
| December 15, 2025 | Effective date for ASU 2025-05, Financial Instruments Credit Losses (Topic 326), for fiscal years beginning after this date. |
| January 3, 2026 | Fiscal year ended and balance sheet date. |
| January 4, 2026 | Commencement of the current fiscal year and the three-month period ended March 31, 2026. |
| January 5, 2026 | OECD announced new administrative guidance under the Pillar Two global minimum tax rules. |
| February 18, 2026 | Board of Directors changed the company's fiscal year-end to December 31. |
| February 24, 2026 | Annual Report on Form 10-K for the fiscal year ended January 3, 2026, filed with the SEC. |
| February 24, 2026 | Yoon Ah E. Oh adopted a Rule 10b5-1 trading arrangement. |
| February 25, 2026 | Ido Dolev adopted a Rule 10b5-1 trading arrangement. |
| March 9, 2026 | Michael P. Plisinski adopted a Rule 10b5-1 trading arrangement. |
| March 31, 2026 | End of the current fiscal quarter. |
| April 20, 2026 | Company entered into a definitive share purchase agreement to acquire 27% of Rigaku Holdings Corporation. |
| April 20, 2026 | Company entered into a commitment letter with Goldman Sachs Bank USA for a $500 million bridge term loan credit facility. |
| May 1, 2026 | Number of outstanding shares of common stock was 49,743,567. |
| May 5, 2026 | Filing date of the Form 10-Q. |
| Second half of 2026 | Expected closing of the Rigaku Holdings Corporation acquisition. |
| December 15, 2026 | Effective date for ASU 2025-09 for public business entities for fiscal years beginning after this date. |
| December 15, 2026 | Effective date for ASU 2024-03 for annual periods beginning after this date. |
| January 31, 2027 | End date for Michael P. Plisinski's Rule 10b5-1 trading arrangement. |
| February 24, 2027 | End date for Yoon Ah E. Oh's and Ido Dolev's Rule 10b5-1 trading arrangements. |
| December 15, 2027 | Effective date for ASU 2025-06 for annual periods beginning after this date. |
| December 15, 2027 | Effective date for ASU 2024-03 for interim periods within fiscal years beginning after this date. |
| 2028 | Effective date for ASU 2025-11 for interim periods. |
| 2029 | Effective date for ASU 2025-10 for annual and interim periods. |
Recommendation
holdWhile Onto Innovation demonstrated revenue growth and made a significant strategic investment in Rigaku, the substantial decline in net income, diluted EPS, gross profit margin, and operating cash flow for the quarter raises concerns about short-term profitability and operational efficiency. The increased operating expenses and restructuring costs indicate ongoing integration and transformation efforts. An investor would likely hold to observe the successful integration of Semilab USA, the closing and initial impact of the Rigaku investment, and any improvements in profitability metrics in subsequent quarters before making a stronger directional call.
Keywords
Semiconductor equipment, Process control, Metrology, Defect inspection, Lithography, Advanced packaging, Semilab USA, Rigaku Holdings, Acquisition, Financial results, Q1 2026, Earnings, Revenue, Net income, Operating expenses, Cash flow, Marketable securities, Share repurchase, Corporate governance, Rule 10b5-1, Supply chain, Geopolitical risk, Intellectual property, Tax policy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.